| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc9c4dfc260223af3e25076428354c57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b7fa82c862e4cd5cd306fbd221290d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1aa1adc9b3f7332dde46a80894cb0ca4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L2-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-234
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-047 |
| filingDate |
2003-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c63f5660098216f3edb6eeb426c092f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d3aad1fa515f95789c47e8ca98dc1a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f303c18ae38d1a48ef9ba7a4ec9f3048 |
| publicationDate |
2004-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20040069413-A |
| titleOfInvention |
Pharmaceutical composition comprising the falcarindiol derivatives having neuro-protective activity |
| abstract |
The present invention relates to a composition for the prevention and treatment of neurological diseases that inhibit neuroprotective and neuronal cell death containing falcarindiol derivative compounds isolated from Cnidium officinale MAKINO.n n n The compound of the present invention significantly inhibits nitric oxide and induced nitric oxide synthase (iNOS) that induces it in a lipopolysaccharide-activated cell population, thereby providing pharmaceuticals and health foods useful for the prevention and treatment of neurological diseases such as stroke. can do. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105816495-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220150554-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112494491-A |
| priorityDate |
2003-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |